logo image

HIV Molecular Immunology Database

Search Antibody Database

Found 1 matching record:

Displaying record number 2937

Download this epitope record as JSON.

MAb ID H003830 (3830)
HXB2 Location Env Env Epitope Map
Author Location  
Epitope
Subtype B
Ab Type gp120
Neutralizing  
Species (Isotype) human(IgG1)
Patient  
Immunogen vaccine
Country Belgium
Keywords antibody generation, cell-line isolated antibody, recombinant antibodies, vaccine-induced immune responses

Vaccine Details

Vaccine type recombinant protein
Vaccine strain B clade W61D
Vaccine component Env, gp120, Nef, Tat
Adjuvant AS01B

Notes

Showing 1 of 1 note.

References

Showing 2 of 2 reference.

Isolation Paper
Moody2012 M. Anthony Moody, Nicole L. Yates, Joshua D. Amos, Mark S. Drinker, Joshua A. Eudailey, Thaddeus C. Gurley, Dawn J. Marshall, John F. Whitesides, Xi Chen, Andrew Foulger, Jae-Sung Yu, Ruijun Zhang, R. Ryan Meyerhoff, Robert Parks, Julia Cavanaugh Scull, Lu Wang, Nathan A. Vandergrift, Joy Pickeral, Justin Pollara, Garnett Kelsoe, S Munir Alam, Guido Ferrari, David C. Montefiori, Gerald Voss, Hua-Xin Liao, Georgia D. Tomaras, and Barton F. Haynes. HIV-1 gp120 Vaccine Induces Affinity Maturation in Both New and Persistent Antibody Clonal Lineages. J. Virol., 86(14):7496-7507, Jul 2012. PubMed ID: 22553329. Show all entries for this paper.

Leroux-Roels2010 Isabel Leroux-Roels, Marguerite Koutsoukos, Frédéric Clement, Sophia Steyaert, Michel Janssens, Patricia Bourguignon, Kristen Cohen, Marcus Altfeld, Pierre Vandepapelière, Louise Pedneault, Lisa McNally, Geert Leroux-Roels, and Gerald Voss. Strong and Persistent CD4+ T-Cell Response in Healthy Adults Immunized with a Candidate HIV-1 Vaccine Containing gp120, Nef and Tat Antigens Formulated in Three Adjuvant Systems. Vaccine, 28(43):7016-7024, 8 Oct 2010. PubMed ID: 20728522. Show all entries for this paper.


This is a legacy search page. It is deprecated, will receive no more updates, and will eventually be removed. Please use the new search pages.

Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration
Copyright Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services LANL logo National Institutes of Health logo